Palliative Care

Top Story

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress
October 17, 2017

Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized the importance of robust medical research funding.

Webinar participants also provided updates on the seventh annual AACR Cancer Progress Report, released last month. The report — titled “Harnessing Research Discoveries to Save Lives” — provided a snapshot of cancer progress this year, and also offered recommendations to increase public understanding and advocate for increased federal funding.

Meeting News

Early palliative care does not show quality-of-life benefit for newly diagnosed mesothelioma

October 16, 2017
Early palliative care did not significantly improve quality-of-life measures among patients newly diagnosed with malignant pleural mesothelioma, according to results of…
In the Journals Plus

Hospitalization burden heavy after advanced cancer diagnosis

October 12, 2017
Patients with advanced cancer face a heavy burden of hospitalization in the year following diagnosis, study data showed. Researchers recommended efforts to reduce
In the Journals

Race does not impact quality of palliative care

October 11, 2017
Researchers did not observe significant racial differences in various aspects of end-of-life care in the United States; however, they reported that both black and white…
More Headlines »
CME

Bridging the Gap from Knowledge to Practice in CRPC

This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.

The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review…
More »
Video

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Advertisement
Advertisement